BDTX | Black Diamond Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.5150 - 1.5900
52 Week Range	1.5103 - 7.66
Beta	3.58
Implied Volatility	191.93%
IV Rank	37.72%
Day's Volume	1,834,243
Average Volume	3,408,828
Shares Outstanding	56,662,200
Market Cap	87,826,410
Sector	Healthcare
Industry	Biotechnology
IPO Date	2020-01-31

Valuation
Profitability
Growth
Health
P/E Ratio	-1.22
Forward P/E Ratio	-0.95
EPS	-1.27
1YR Price Target	3.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	54
Country	USA
Website	BDTX

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535.

BDTX's peers: ABEO, ACIU, ADAP, ADCT, AGIO, AKRO, ALEC, ALXO, ARCT, ARVN, PASG, TCRR, HARP, RVMD, BCEL, STOK, FIXX, CABA, CRNX, CYTK, DARE, DNLI, DTIL, ERAS, ETON, EWTX, FDMT, GOSS, IGMS, NKTX, NRIX, PLRX, PRLD, PTGX, QSI, RAPT, RLAY, RNA, RYTM, SAGE, SLDB, SRRK, SWTX, TCRT, TNGX, YMAB, IVVD, PROK

*Chart delayed

Analyzing fundamentals for BDTX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see BDTX Fundamentals page.

Watching at BDTX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BDTX Technicals page.